CSIMarket
 
Biocept Inc.  (BIOC)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 


The Medical Laboratories company has failed to turn into profitability regardless of epic Surge in Revenues

BIOC announced first quarter of 2022 operating deficit of $-2.707 millions

Published 2022-05-24T15:30:33-04:00
Goran Soko / CSIMarket.com Contributer

BIOC announced very robust Revenue advance of 2073.911 % year on year to $19.95 millions in the most recent fiscal period, but increased a shortfall per share at $-0.16.

from the prior financial reporting period EPS fell from $0.13 per share and Revenue Tumbled by -61.863 % from $52.30 millions.


In the financial period ending March 31 2022 Biocept Inc. reported net shortfall of $-2.768 million, instead of deficit of $-6.489 millions in the comparable financial reporting period a year ago.


Biocept Inc. is expected to report next financial recent numbers on November 14, 2022.


    Recently Reported Results
29186943363_88cb6b059f_z Barnwell Industries Inc.

Compelling quarter by BRN in the April to June 30 2022 interval

BRN announced earnings per share of $0.25 and Revenue of $6.68 millions in the financial interval ending June 30 2022, Barnwell Industries Inc.s' earnings per share plummeted $0.25 per share, versus $0.59 eps, earned in the similar interval a year before, although the Oil And Gas Production company saw its Revenue rise by 56.981 % in the similar period.


Montage_By_Michael_Schmahl_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Construction Spending

U.S. construction spending dropped in the June 2022

Outlays for U.S. construction projects fell after recent increases, as decline in private spending offset an increase in public spending.

Medical_ultrasound_examination_pd Star Equity Holdings Inc.

Smooth rise by Star Equity Holdings Inc. during the April to June 30 2022 three months

For the financial period ending June 30 2022 Star Equity Holdings Inc. decreased loss per share of $-0.10 per share compare to $-0.37 a year prior and EPS improved from $-0.29 per share from the preceding financial reporting period.

Revenues rose substantially by 19.034 % to $30.72 millions from $25.81 millions in the corresponding financial reporting period a year prior and sequentially Revenues improved by 22.632 % from $25.05 millions.


ATM_nice_pd Colony Bankcorp Inc.

Regardless of the very notable Revenues EPS fell the Colony Bankcorp Inc. during the second quarter of 2022 earnings season

CBAN announced income per share of $0.19 and Revenue of $28.29 millions in the Jun 30 2022 report, Colony Bankcorp Inc.s' income per share plummeted $0.19 per share, versus $0.42 eps, earned in the corresponding span a prior year, although the Regional Banks company saw its Revenue rise by 23.247 % in the corresponding period.


architecture-2256489_960_720 Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc. declared that Revenues have faded, all along the fiscal three months ending June 30 2022

For the April to June 30 2022 time-frame TCI profitability turned positive of $1.91 per share compare to $-3.56 a year ago and net profit per share grew by 13.69 % from $1.68 per share from the preceding financial reporting period.

Revenues crumbled by -28.022 % to $7.77 millions from $10.80 millions in the corresponding financial reporting period a year ago and sequentially Revenue decreased by -0.218 % from $7.79 millions.


Loxley_Farm_Market_Produce_By_Infrogmation_of_New_Orleans_[CC-BY-SA-3.0_(http_creativecommons.org_licensesby-sa3.0)]_via_Wikimedia_Commons Consumer Price Index

Inflation accelerates in June 2022

Prices increased on the faster pace again, adding to inflationary worries.

unemployed_lines_pd Employment Report

Economy gains 528,000 jobs in July 2022, unemployment rate 3.5 %

The nonfarm payrolls grew 528,000 in July 2022, as faster hiring puts more money in the hands of consumers, what usually leads to an increase in spending,

turn-on-2932999__340 Producer Price Index

Inflation higher in June 2022

Prices increased on the faster pace again, adding to inflationary worries.

Red_pill_wikipedia_By_FML_(Own_work)_[CC-BY-SA-2.5_(http_creativecommons.org_licenses_by-sa_2.5)]_via_Wikimedia_Commons Brickell Biotech Inc.

The Biotechnology & Pharmaceuticals company disclosed that BBI went from strength to strength, during the financial span closing Jun 30 2022

For the fiscal period ending June 30 2022 company decreased loss per share of $-0.01 per share compare to $-0.16 a year prior and EPS improved from $-0.08 per share from the prior financial reporting period.

Revenues grew sharply by 2757.616 % to $4.32 millions from $0.15 millions in the corresponding financial reporting period a year prior and sequentially Revenue doubled by 4590.217 % from $0.09 millions.


pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Spectrum Pharmaceuticals Inc.

Spectrum Pharmaceuticals Inc. created some great story for the investors, posting a significant growth in Jun 30 2022 report with operating loss of $-25.392 millions

While the April to June 30 2022 reporting cycle continues, countless corporations have disclosed the respective numbers. Among them, are multiple businesses in the Major Pharmaceutical Preparations industry. As well as, today, SPPI published operating loss of $-25.392 millions, for the financial span closing Jun 30 2022.


Khozam_By_BandarSar_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Frp Holdings Inc.

Frp Holdings Inc. declared relevant 13.337%, Revenues rise , during the fiscal span closing Jun 30 2022

Directin the attention to the April to June 30 2022 earnings per share soared by 600 % to $0.07 per share, followed by Revenue increase of 13.337 % to $9.63 millions, compared with the prior year period.


20_Dollar_bills3_Source_selbstfotografiert_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Riverview Bancorp Inc

Inconsequential -4.159 %, contruction in Revenues at the company in the most recent fiscal period

RVSB reported soft recent numbers for the most recent fiscal period, where income fell by -19.23 % to $0.21 per share and Revenue decreased by -4.159 % to $15.79 millions, year on year.


Savings_Bank_By_Ccyyrree_(Own_work)__(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Resmed Inc.

Was 4.01%, advance adequate at Resmed Inc. in the fiscal fourth quarter of 2022

Resmed Inc. had fiscal fourth quarter of 2022 Revenue advance of 4.01 % to $1.30 billions from $1.25 billions from the same reporting season a year prior, Resmed Inc. grew eps by 0.29 % to $1.32, from $1.32 in the prior year reporting season.


Chute_libre_en_Normandie_By_Dregcla_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Utg Inc.

Utg Inc. reported it had very pressing period, amid the fiscal span ending June 30 2022

the Life Insurance company announced disappointing fiscal span ending June 30 2022, where Revenue melted down by -33.021 % to $5.26 millions and the Utg Inc. posted a shortfall per share to $-0.24, in proportion to $0.57, in the fiscal span ending June 30 2021.




Other BIOC's Earnings Reports

Biocept reported first quarter 2022 earnings

Biocept reported fourth quarter 2021 earnings

Biocept reported third quarter 2021 earnings

       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HOUR's Profile

Stock Price

HOUR's Financials

Business Description

Fundamentals

Charts & Quotes

HOUR's News

Suppliers

HOUR's Competitors

Customers & Markets

Economic Indicators

HOUR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071